Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea for Pulmonary Hypertension in Sickle Cell Disease
NCT00350844Phase 2Terminated
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Jul 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxyurea in pulmonary hypertension (PH), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoint: Mean Reduction in Tricuspid Regurgitant Jet Velocity at 12 months. Started Jul 2006; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00350844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350844.